 | Up a level |
Journal Article
Chung, W. H., van Dijk, E. H. C., Mohabati, D., Dijkman, G., Yzer, S., de Jong, E. K., Fauser, S., Schlingemann, R. O., Hoyng, C. B. and Boon, C. J. F. (2017). Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Acta Ophthalmol., 95. S. 23 - 24. HOBOKEN: WILEY. ISSN 1755-3768
Mohabati, D., van Dijk, E. H. C., van Rijssen, T. J., de Jong, E. K., Breukink, M. B., Martinez-Ciriano, J. P., Dijkman, G., Hoyng, C. B., Fauser, S., Yzer, S. and Boon, C. J. F. (2017). Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Schellevis, R. L., van Dijk, E. H. C., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., Boon, C. J. F. and de Jong, E. K. (2017). A genetic variant in the NR3C2 gene, encoding the mineralocorticoid receptor, is associated with chronic central serous chorioretinopathy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Schreur, V., Altay, L., van Asten, F., Groenewoud, J. J. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). Hyperreflective foci predict treatment response to bevacizumab in patients with diabetic macular edema. Acta Ophthalmol., 95. S. 19 - 20. HOBOKEN: WILEY. ISSN 1755-3768
Schreur, V., Altay, L., van Asten, F., Groenewoud, J. M. M., Klevering, B. J., Hoyng, C. B. and de Jong, E. K. (2017). HYPERREFLECTIVE FOCI PREDICT TREATMENT RESPONSE TO BEVACIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA. Eur. J. Ophthalmol., 27 (3). S. E119 - 1. MILAN: WICHTIG PUBLISHING. ISSN 1724-6016